Agilent technologies and exact sciences agree to terms of sale for resolution bioscience

Santa clara, calif. & madison, wis.--(business wire)--agilent technologies, inc. (nyse: a) and exact sciences corp. (nasdaq: exas), a leading provider of cancer screening and diagnostic tests, today announced they have entered into a definitive agreement for the sale of resolution bioscience to exact sciences. financial terms of the agreement were not disclosed and are not material to either party. “we are pleased that exact sciences is acquiring resolution bioscience,” said sam raha, senior vi.
A Ratings Summary
A Quant Ranking